期刊文献+

酒精性肝病常见临床综合征 被引量:4

Alcoholic liver disease: common clinical syndromes
下载PDF
导出
摘要 酒精性肝病仅次于病毒性肝硬化已经成为终末期肝病的重要病因,但过量饮酒对身体造成的损伤并没有得到广泛关注,特别是一些中晚期的临床综合征,如马德龙综合征、假性布加综合症、酒精诱发的骨病、酒精戒断综合征等已经显现,临床上还不能得到准确认识和及时治疗,导致一些不可逆的损伤。通过介绍这4种综合征的临床表现、可能机制、治疗原则,旨在提高临床医师重视这些过量饮酒的信号,及早预防和阻止酒精性肝硬化的发生与发展;对于酒精戒断综合征的早期认识和及时有效的治疗,不仅能够减少误诊误治,还可减少重症监护状态下患者的病死率。 Alcoholic liver disease (ALD) has become a major cause of end - stage liver disease after viral liver cirrhosis. However, the im- pairments due to excessive alcohol intake have not drawn much attention, especially some clinical syndromes that occur in the advanced stage of ALD, such as Madelung syndrome, pseudo Budd - Chiari syndrome, hepatic osteodystrophy, and alcohol withdrawal syndrome (AWS). There is no accurate recognition and timely treatment of these syndromes, thus leading to irreversible damage. The clinical manifestation, possible mechanism, and therapeutic principle of the four syndromes are reviewed, aiming to increase the clinicians' awareness of these sig- nals of excessive drinking and to prevent the development and progression of ALD. Early diagnosis of AWS, as well as timely, effective treat- ment, can not only reduce misdiagnosis and mistreatment, but also reduce the mortality of patients under intensive care.
作者 张岱 王炳元
出处 《临床肝胆病杂志》 CAS 2014年第2期121-123,共3页 Journal of Clinical Hepatology
关键词 肝疾病 酒精性 脂肪瘤样病 多发性对称性 假性布加综合征 骨疾病 代谢性 戒酒性谵妄 综述 liver diseases, alcoholic lipomatosis, muttiple symmetrical pseudo -Budd - Chiari syndrome bones diseases, metabolic alcohol withdrawal delirium review
  • 相关文献

参考文献2

二级参考文献54

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 2刘畅,王颖,王炳元,常冰,贺小虎,向国卿,孟晓丹.88例酒精性肝炎临床特征及疗效分析[J].药品评价,2007,4(2):110-113. 被引量:7
  • 3Sass DA,Shaikh OS.Alcoholic hepatitis[J].Clin Liver Dis,2006,10 (2):219-237.
  • 4Forman LM,Lucey MR.Predicting the prognusis of chronic liver disease:an evolution from child to MELD.Mayo End-stage Liver Disease[J].Hepatology,2001,33(2):473-475.
  • 5Verma S,Ajudia K,Mendler M,et al.Prevalence of septic events,type 1 hepatorenal syndrome,and morlallty in severe alcoholic hepatitis and utility ot discriminant function and MELD score in predicting these adverse events[J].Dig Dis Sci,2006,51(9):1637-1643.
  • 6Forrest EH,Evans CD,Stewart S,et al.Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score[J].Gut,2005,54(8):1057-1059.
  • 7Mendenhall CL,Anderson S,Gareia PP,et al.Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone[J].N Engl J Med,1984,311(23):1464-1470.
  • 8Charhon M.Branched-chain amino acid enriched supplements as therapy for liver disease[J].J Nutr,2006,136(1):295S-298S.
  • 9Mendenhall CL,Moritz TE,Roselle GA,et al.A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis:results of a Deparlment of Veterans Affairs cooperative study[J].Hepatology,1993,17(4):564-576.
  • 10Morris JM,Forrest EH.Bilirubin response to eorticosteroids in severe alcoholic hepatitis[J].Eur J Gastrocnterol Hepatol,2005,17(7):759-762.

共引文献4

同被引文献67

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部